currently enrolling clinical trials for IBC

(Designed for IBC patients or building on IBC research)

Home » Clinical Trials

Ruxolitinib + chemo upfront TN-IBC

Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as INCB018242. Paclitaxel is often shortened as “taxol”. “AC” is short for adriamycin and cyclophosphamide. Doxorubicin is another name for Adriamycin. Cyclophosphamide may also be...

How To Navigate

Pick a trial on the previous screen and scroll to bottom to choose a category to perform a search for trials that fit your situation. Alternatively, browse all the trials in order - the order is simply the reverse chronological sequence that they were added to the...

Eribulin-AC HER2- IBC

Alternative Drug Names: Eribulin is also known as Halaven (US brand name) and previously known as B1939 mesylate. “AC” is short for adriamycin and cyclophosphamide. Doxorubicin is another name for Adriamycin. Cyclophosphamide may also be called Cytoxan (brand name)....

ACE for metastatic IBC

Alternative Drug Names: Atezolizumab is also known as Tecentriq. Cobimetinib is also known as Cotellic. Eribulin is also called Halavan. Purpose of Trial: This is a trial of a novel combination for chemotherapy-resistant metastatic IBC. The purpose is to determine the...

Adjuvant Keytuda ER+ stage 3 IBC

Alternative Drug Names: Keytruda is the brand name for Pembrolizumab. It used to be called MK-3475 Purpose of Trial: This trial is testing the concept that activating the immune system in patients who had residual alive cancer at mastectomy will reduce recurrence more...

IBC Skin Metastases Project

Our purpose is to fund research.  We met Ria, and her project in Dr. Kenneth van Golen's lab at the University of Delaware has some interesting questions that need to be answered.  We have made a commitment to her and Dr. van Golen to support this research.  IBC Skin...

Dual HER2 + Abraxane

Alternative Drug Names: Nab-Paclitaxel (Abraxane brand in the US), Trastuzumab (Herceptin is the brand in the US and abroad), Pertuzumab (Perjeta brand in the US and abroad) Purpose of Trial: The purpose of this phase 2 study is to evaluate the effectiveness of the 3...

Ruxolitinib + Paclitaxel IBC

Alternative Drug Names: Ruxolitinib (Jakafi brand in the US) was previously also known as INCB018242. Purpose of Trial: The purpose of this phase 1/2 study is 2-fold. In the first part of the study in metastatic breast cancer patients, the goal is to determine a safe...

Pin It on Pinterest

Share This
X